Glaxosmithkline Pharma Ltd


BSE: 500660 | NSE: GLAXO | ISIN: INE159A01016 
Market Cap: [Rs.Cr.] 16,862 | Face Value: [Rs.] 10
Industry: Pharmaceuticals - Multinational

 Discuss this stock

Balance Sheet

(Rs. in Crores)
ParticularsDec-11Dec-10Dec-09Dec-08Dec-07Dec-06
SOURCES OF FUNDS :      
Share Capital 84.7084.7084.7084.7084.7084.70
Reserves Total 1,835.231,846.111,674.451,456.391,276.221,110.01
Total Shareholders Funds1,919.931,930.811,759.151,541.091,360.921,194.71
Secured Loans 0.000.000.000.000.000.00
Unsecured Loans 4.915.165.425.655.765.54
Total Debt4.915.165.425.655.765.54
Total Liabilities1,924.841,935.971,764.571,546.741,366.681,200.25
APPLICATION OF FUNDS :      
Gross Block 271.66318.40289.18282.15266.71253.63
Less : Accumulated Depreciation 172.53209.47196.37191.75179.24167.83
Less:Impairment of Assets0.000.000.000.000.000.00
Net Block 99.13108.9392.8190.4087.4785.80
Lease Adjustment0.000.000.000.000.000.00
Capital Work in Progress25.418.7221.369.955.438.66
Investments 159.80160.35190.91751.871,333.321,139.41
Current Assets, Loans & Advances      
Inventories 330.14281.54253.02228.38205.96240.95
Sundry Debtors 85.3147.0253.7357.9437.7760.45
Cash and Bank1,986.381,948.081,672.60906.54154.9935.03
Loans and Advances 294.04171.69135.07198.17158.921,430.35
Total Current Assets2,695.872,448.332,114.421,391.03557.641,766.78
Less : Current Liabilities and Provisions      
Current Liabilities 354.54346.22316.66271.60244.78247.72
Provisions 762.30500.54382.96454.50392.541,577.29
Total Current Liabilities1,116.84846.76699.62726.10637.321,825.01
Net Current Assets1,579.031,601.571,414.80664.93-79.68-58.23
Miscellaneous Expenses not written off 0.000.000.000.000.000.00
Deferred Tax Assets67.4365.1452.2838.7029.9635.19
Deferred Tax Liability5.968.747.599.119.8210.58
Net Deferred Tax61.4756.4044.6929.5920.1424.61
Total Assets1,924.841,935.971,764.571,546.741,366.681,200.25
Contingent Liabilities277.32214.51204.66183.64179.24194.19

Peer Comparison

Company Market Cap
(Rs. in Cr.)
P/E (TTM)
(x)
P/BV (TTM)
(x)
EV/EBIDTA
(x)
ROE
(%)
ROCE
(%)
D/E
(x)
Glaxosmit Pharma 16,861.65 26.69 8.78 23.27 30.7 47.7 0.00
Sanofi India 4,783.79 26.47 4.33 16.19 18.2 27.0 0.00
Astrazeneca Phar 4,697.00 237.52 24.81 27.64 31.7 49.8 0.00
Pfizer 3,488.45 18.87 2.67 8.63 15.7 24.0 0.00
Abbott India 3,133.74 26.67 5.76 14.58 28.3 42.4 0.00
Novartis India 2,355.93 15.50 2.88 8.97 22.6 33.8 0.00
Wyeth 1,980.28 13.69 4.05 6.89 37.4 53.1 0.01
Merck 960.73 18.09 2.34 8.45 16.8 25.3 0.00
Fulford (India) 253.50 0.00 1.69 12.29 1.2 1.9 0.00
Organon (India) 159.14 0.00 0.98 0.00 15.3 22.8 0.00

Futures & Options Quote

 
Expiry Date
NA
Instrument: NA
Expiry Date: NA
Strike Price: NA
Open Price: NA
Average Price: NA
No. of Contracts Traded: NA
Open Interest: NA
Underlying: NA
Option Type: NA
Market Lot: NA
Previous Close: NA
Day’s High | Low: NA | NA
Turnover (Cr.): NA
Open Int. Change: NA | NA
View detailed F& O quotes >>

Key Information

Key Executives:

D S Parekh , Chairman 

V Thyagarajan , Vice Chairman 

H B Joshipura , Managing Director 

R R Bajaaj , Director 


Company Head Office / Quarters:
GSK House,
Dr Annie Besant Road Worli,
Mumbai,
Maharashtra-400030
Phone : 91-022-24959595
Fax : 91-022-24959494
E-mail : ajay.a.nadkarni@gsk.com
Web : http://www.gsk-india.com
Registrars:
Karvy Computershare Pvt Ltd
Plot No 17-24
Vittal Rao Nagar
Madhapur
Hyderabad-500081

Calendar

May-2012
M T W T F S S
21 22 23 24 25 26 27
IPO
listNo IPO today
Economic Events
list No economic event today
Results
list Videocon Inds. | Rel. Comm.